RERE

Zacks Small Cap Research – RERE 1Q25 Earnings Review: EPS Strength Beneath the Surface; Rising Trade-In Activity Increasingly Driving Growth – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 5/20/25, ATRenew (NYSE:RERE) reported 1Q25 earnings results. On a GAAP basis, RERE reported net income of $5.9 million for 1Q25, or $0.02 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.04, or … Read more

Zacks Small Cap Research – RERE: 4Q24 Earnings Review: EPS as Expected; Investing for Growth to Keep Pace with Accelerating Demand – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 3/11/25, ATRenew (NYSE:RERE) reported 4Q24 earnings results. On a GAAP basis, RERE reported net income of $10.6 million for 4Q24, or $0.04 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.07, or … Read more